Physician profile
Teodor Georgescu
NPI 1417989955
$571.85
in general payments reported to CMS, 2019-2025
9 companies · $55.50 in 2025
The $55.50 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.42 · 2020: $31.81 · 2021: $55.51 · 2022: $98.65 · 2023: $163 · 2024: $133 · 2025: $55.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $187.43 | 2020-2025 | Vaxelis, Gardasil 9, M-M-R II |
| Pfizer INC. | $165.07 | 2019-2025 | |
| Seqirus USA INC | $47.23 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Cranial Technologies, INC | $42.67 | 2024 | Doc Band |
| Verrica Pharmaceuticals INC. | $41.80 | 2023-2024 | Ycanth |
| Corium, LLC | $34.56 | 2022 | |
| Alk-Abello, INC | $20.70 | 2023 | Grastek, Ragwitek, Odactra |
| Supernus Pharmaceuticals, INC. | $17.52 | 2021 | |
| Tris Pharma INC | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teodor Georgescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.